Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data

EUROCARE-4 Working Group, Arduino Verdecchia, Silvia Francisci, Hermann Brenner, Gemma Gatta, Andrea Micheli, Lucia Mangone, Ian Kunkler

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Traditional cancer-survival analyses provide data on cancer management at the beginning of a study period, and are often not relevant to current practice because they refer to survival of patients treated with older regimens that might no longer be used. Therefore, shortening the delay in providing survival estimates is desirable. Period analysis can estimate cancer survival by the use of recent data. We aimed to apply the period-analysis method to data that were collected by European cancer registries to estimate recent survival by country and cancer site, and to assess survival changes in Europe. We also compared our findings with data on cancer survival in the USA from the US SEER (Surveillance, Epidemiology, and End Results) programme.
Original languageEnglish
Pages (from-to)784-96
Number of pages13
JournalThe Lancet Oncology
Issue number9
Publication statusPublished - Sept 2007

Keywords / Materials (for Non-textual outputs)

  • Age of Onset
  • Europe
  • Health Surveys
  • Humans
  • Neoplasms
  • Registries
  • SEER Program
  • Survival Analysis


Dive into the research topics of 'Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data'. Together they form a unique fingerprint.

Cite this